open access

Vol 22, No 3 (2015)
Original articles
Published online: 2015-06-19
Get Citation

Usefulness of the uric acid and CHA2DS2-VASc score in prediction of left atrial thrombosis in patients with mitral stenosis and sinus rhythm

Derya Ozturk, Omer Celık, Fatıh Akın, Faruk Akturk, Serkan Aslan, Sınem Ozbay Ozyılmaz, Alı Bırand, Aydın Yıldırım
DOI: 10.5603/CJ.a2014.0059
·
Pubmed: 25179317
·
Cardiol J 2015;22(3):336-342.

open access

Vol 22, No 3 (2015)
Original articles
Published online: 2015-06-19

Abstract

Background: The risk of thrombus formation in the left atrium is known to be very high in patients with both mitral stenosis (MS) and atrial fibrillation (AF). However, that risk should not be ignored in patients with MS in sinus rhythm (SR). The aim of this study was to determine the clinical, echocardiographic, and biochemical factors that could have a determining role in the formation of a left atrial (LA) thrombus in patients with MS in SR.

Method: A total of 207 consecutive patients with MS who underwent both transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) for diagnosis or to investigate the presence of a thrombus in the LA and appendage were enrolled in this study.

Results: LA thrombus was detected in 21 of 207 patients. CHA2DS2-VASc score was not found to be a predictor of LA thrombosis in patients with MS in SR, despite the higher CHA2DS2-VASc scores observed in those patients. The mitral valve area and mitral valve gradient were not predictive of LA thrombus development; however, LA anteroposterior diameter (LAAPD) was found to be a predictor of LA thrombosis. Levels of high sensitivity-C-reactive protein and uric acid were higher in the patients with LA thrombosis, but only uric acid was found to be a predictor of LA thrombosis in multivariate analysis.

Conclusions: A larger LAAPD and an elevated serum uric acid level were found to be independent predictors of LA thrombosis in patients with MS in SR.

Abstract

Background: The risk of thrombus formation in the left atrium is known to be very high in patients with both mitral stenosis (MS) and atrial fibrillation (AF). However, that risk should not be ignored in patients with MS in sinus rhythm (SR). The aim of this study was to determine the clinical, echocardiographic, and biochemical factors that could have a determining role in the formation of a left atrial (LA) thrombus in patients with MS in SR.

Method: A total of 207 consecutive patients with MS who underwent both transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) for diagnosis or to investigate the presence of a thrombus in the LA and appendage were enrolled in this study.

Results: LA thrombus was detected in 21 of 207 patients. CHA2DS2-VASc score was not found to be a predictor of LA thrombosis in patients with MS in SR, despite the higher CHA2DS2-VASc scores observed in those patients. The mitral valve area and mitral valve gradient were not predictive of LA thrombus development; however, LA anteroposterior diameter (LAAPD) was found to be a predictor of LA thrombosis. Levels of high sensitivity-C-reactive protein and uric acid were higher in the patients with LA thrombosis, but only uric acid was found to be a predictor of LA thrombosis in multivariate analysis.

Conclusions: A larger LAAPD and an elevated serum uric acid level were found to be independent predictors of LA thrombosis in patients with MS in SR.

Get Citation

Keywords

mitral stenosis, sinus rhythm, left atrial thrombosis, uric acid, CHA2DS2-VASc score

About this article
Title

Usefulness of the uric acid and CHA2DS2-VASc score in prediction of left atrial thrombosis in patients with mitral stenosis and sinus rhythm

Journal

Cardiology Journal

Issue

Vol 22, No 3 (2015)

Pages

336-342

Published online

2015-06-19

DOI

10.5603/CJ.a2014.0059

Pubmed

25179317

Bibliographic record

Cardiol J 2015;22(3):336-342.

Keywords

mitral stenosis
sinus rhythm
left atrial thrombosis
uric acid
CHA2DS2-VASc score

Authors

Derya Ozturk
Omer Celık
Fatıh Akın
Faruk Akturk
Serkan Aslan
Sınem Ozbay Ozyılmaz
Alı Bırand
Aydın Yıldırım

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl